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Accepted 21 October; published on WWW 8 December 1998The E-cadherin/catenin complex, an organizer of epithelial
structure and function, is disturbed in invasive cancer. The
HAV (histidine alanine valine) sequence in the first
extracellular domain of E-cadherin is crucial for
homophilic interactions between cadherins. We report that
specific peptides containing an HAV sequence interfere
with the functions of the E-cadherin/catenin complex. Cells
either expressing specific cadherins or not were challenged
with both cadherin and noncadherin peptides comprising
a central HAV sequence. Specific E-cadherin peptides
inhibited cell aggregation, disturbed the epithelial
morphotype and were able to stimulate invasion of cells
expressing E-cadherins. Conditioned medium, containing
E-cadherin fragments, also stimulated invasion in contrast
to conditioned medium from which the E-cadherin
fragments were removed. Our studies show that E-
cadherin functions are inhibited by homologous proteolytic
HAV-containing fragments that are released in an
autocrine manner and subsequently inhibit the E-
cadherin/catenin complex. In this way such cadherin
fragments may induce and support cancer invasion.
Key words: E-cadherin/catenin, HAV peptide, Cell-cell adhesion,
Invasion, Cadherin fragment
SUMMARYINTRODUCTION
Cadherins are a family of closely related calcium-dependent
cell-cell adhesion and signal-transducing integral membrane
glycoproteins (Takeichi, 1995). They form complexes with the
catenins, intracellular proteins of the armadillo family. The E-
cadherin/catenin complex is necessary for development and
maintenance of epithelial organisation. Dysfunction of the E-
cadherin/catenin complex has been correlated with malignancy
as evidenced by tumor progression, loss of differentiation,
invasion, metastasis and poor prognosis (Behrens et al., 1989;
Vleminckx et al., 1991; Takeichi et al., 1993; Birchmeier et al.,
1993; Mareel et al., 1994). Cadherins are expressed in a tissue-
specific manner as exemplified by the classical cadherins: E-
(epithelial), P-(placental) and N-(neural) cadherin (Takeichi,
1991). The extracellular part of E-cadherin contains a tandemly
repeated sequence and consists of 5 domains forming an
elongated monomeric structure in the presence of calcium
(Pokutta et al., 1994). The first amino (NH2)-terminal
extracellular repeat of the classical cadherins contains a highly
conserved HAV (histidine alanine valine) sequence, that is
crucial for homophilic cadherin interactions. The exact
mechanism of this interaction is, however, still a matter of
debate. Indeed, the structure of the first extracellular repeat of
E-cadherin as determined by nuclear magnetic resonance, didnot reveal dimerisation of E-cadherin fragments (Overduin et
al., 1995). This is in contrast to crystallographic analysis
revealing that the NH2-terminal domain of N-cadherin has a
parallel dimer interface, which links two cadherin molecules
on the same cell through hydrophobic interactions. This
cadherin dimer binds to another cadherin dimer on a
neighbouring cell, so forming an adhesion zipper (Shapiro et
al., 1995). Crystallographic analysis of the first two repeats of
E-cadherin also revealed dimers, linked together by calcium
ions (Nagar et al., 1996), and this structure was confirmed
biochemically by Koch et al. (1997). For homophilic binding
of Xenopus C-cadherin, lateral dimerisation is also required
(Brieher et al., 1996).
The high conservation of the HAV sequence in cadherins
suggests a specific function for this amino acid motif. Next to
classical cadherins, it occurs also in many other proteins some
of which are possibly implicated in cellular interactions,
namely as: FGFR (fibroblast growth factor receptor) (Williams
et al., 1994), influenza hemagglutinins (Byers et al., 1992) and
ECSODB (rat extracellular superoxide dismutase B) (Willems
et al., 1993).
E-cadherin functions can be downregulated at multiple
levels, for instance: by genomic mutations (Becker et al., 1993;
Berx et al., 1996), by tyrosine phosphorylation of b -catenin
(Matsuyoshi et al., 1992; Behrens et al., 1993; Hamaguchi et
128 V. Noë and othersal., 1993) and by disturbance of intracellular associations with
catenins (Hinck et al., 1994; Näthke et al., 1994). In addition
to those ways of functional regulation, protein fragments or
peptides that comprise the HAV sequence may also display
regulatory activity when applied extracellularly. Indeed, a
soluble 80 kDa fragment, purified from the medium of MCF-
7 cell cultures, induced scattering of murine mammary tumor
epithelial cells (Wheelock et al., 1987). This effect was
reversible and could be inhibited by an antibody against gp120,
identical to E-cadherin, from human gestational
choriocarinoma JAR cells. In contrast, neither a glycoprotein
(gp84) trypsinized from murine embryonal carinoma PCC4
cells (Hyafil et al., 1980) nor the recombinant 80 kDa fragment,
harvested from a baculovirus expression system (both derived
from E-cadherin), did have decompacting activity
(Herrenknecht and Kemler, 1993). An N-cadherin-specific
HAV-containing decapeptide inhibited compaction of eight-
cell-stage mouse embryos and outgrowth of rat neurites on
astrocytes, two processes that are mediated by cadherins
(Blaschuk et al., 1990). Neurite outgrowth was also inhibited
by a 12-mer HAV-containing peptide with the sequence found
in FGFR1 or FGFR2 indicating that N-cadherin may signal
also through FGFR (Williams et al., 1994). N-cadherin
dependent myoblast fusion was inhibited by an N-cadherin
peptide (Mège et al., 1992). We found previously that N-
cadherin- and ECSODB-specific HAV-containing decapeptides
inhibit N-cadherin mediated aggregation, whereas E-cadherin-
and P-cadherin-specific HAV peptides block the aggregation of
cells expressing, respectively, E-cadherin and P-cadherin
(Willems et al., 1995). E-cadherin-specific 17-mer HAV
peptides inhibited E-cadherin mediated fusion of monocytes
during the formation of multinucleated bone-resorbing
osteoclasts (Mbalaviele et al., 1995).
The inhibition of cadherin functions by the above
mentioned peptides suggests that cadherin fragments
containing an HAV sequence may stimulate invasion, a
process that is counteracted by the expression of a functional
E-cadherin/catenin complex (Vleminckx et al., 1991). We,
therefore, further investigated the influence of synthetic 10-
mer and 20-mer HAV peptides on cadherin-related functions
of different cell lines. We were able to demonstrate that
synthetic HAV peptides inhibited E-cadherin mediated
cellular interactions and induced invasion in different in vitro
systems. Conditioned medium of E-cadherin expressing cells,
containing E-cadherin fragments, was also able to induce
invasion while conditioned medium from which the E-
cadherin fragments were removed by immunoprecipation did
no longer induce invasion. These results suggest that
extracellular cadherin fragments induce loss of cell-cell
adhesion and lead to tumor cell invasion.
MATERIALS AND METHODS
Cell culture
Cells expressing functional and species specific E-cadherin were
used to test the influence of the HAV peptides on E-cadherin.
MDCKts.srcCl2 (Behrens et al., 1993) are Madin-Darby canine
kidney (MDCK) cells transformed with a temperature sensitive src
oncogene. At the non-permissive temperature for p60v-src activity
(40.5°C), the cells have a functional E-cadherin/catenin complex. At
the src-permissive temperature (35°C), the E-cadherin/catenincomplex loses its function. MDCK-ras-e c5 cells were grown from
microcapsules injected intraperitoneally in nude mice; they express
functional canine E-cadherin (Vandenbossche et al., 1994). NM-f-
ras-TD1 is a cell line derived from an invasive tumor, formed after
subcutaneous injection into nu/nu mice of a fibroblast-like subclone
from a murine mammary gland cell line (NMuMG) transfected with
the ras oncogene (Vleminckx et al., 1991). NM-f-ras-TD1 cells do
not express E-cadherin and were used as a negative control in the
present experiments. The NM-f-ras-TD-CAM5 cell line was derived
from NM-f-ras-TD1 cells after successful cotransfection with the
plasmid pBATEM2, containing the murine E-cadherin cDNA, and
with a plasmid conferring resistance to mycophenolic acid. NM-e-
ras is an epithelioid NMuMG cell clone transfected with the ras
oncogene but still expressing murine E-cadherin. NM-f-ras-TD-
CAM5 and NM-e-ras cells both have a functional E-
cadherin/catenin complex (Vleminckx et al., 1991). The MCF-7/AZ
cell line is a variant of the human breast cancer cell family MCF-7,
that has a functional E-cadherin/catenin complex (Bracke et al.,
1993). 2B2 and ARM cells are S180 mouse sarcoma cells
transfected with and expressing, respectively, chicken E-cadherin
and chicken N-cadherin (Mège et al., 1988). VE-CHO Cl5a cells are
CHO cells transfected with and expressing VE-cadherin (Breviario
et al., 1995).
All cells of the MDCK cell family and VE-CHO Cl5a were
maintained in Dulbecco’s modified Eagle’s medium (DMEM, Life
Technologies, Ghent, Belgium), supplemented with 10% (v/v) fetal
bovine serum (FCS, Life Technologies) and 0.05% (w/v) L-glutamine.
For cells of the NMuMG family, DMEM was supplemented with 10%
fetal bovine serum and 10 m g/ml insulin (Sigma Chemical Company,
St Louis, MO). MCF-7/AZ cells were cultured in EMEM (Earl’s
modified Eagle’s medium, Life Technologies) supplemented with 5%
fetal bovine serum and 6 ng/ml bovine insulin. S180, 2B2 and ARM
cells were maintained in DMEM supplemented with 15% FCS and
0.05% L-glutamine. All media contained 100 units/ml penicillin and
0.1 mg/ml streptomycin.
Peptides, conditioned medium, antibodies and reagents
Different 10-mer and 20-mer HAV-comprizing peptides, similar to
sequences in the amino-terminal part of different cadherins, were used
in the present experiments as well as peptides with the sequence of
other HAV-containing proteins. As controls a scrambled human E-
cadherin 10-mer peptide (hu E-CAD10scr) and 2 peptides containing
the canine E-cadherin HAV flanking amino acids (c E-CAD11flHAV and
c E-CADHAVfl10) were included in the experiments (Table 1).
The human E-cadherin (NH2-LFSHAVSSNG-amide; hu E-CAD10)
differs in the HAV flanking sequences from dog and murine E-
cadherin (LYSHAVSSNG) by only 1 amino acid and from chicken E-
cadherin (LLSHAVSASG) by 3 amino acids. In the rat ECSODB
(NH2-REMHAVSRQV-amide; Ra SOD10) a valine residue was
substituted for an alanine (NH2-REMHAASRQV-amide; Ra
SOD10mut). Conversely, in the human ECSODC, that contains an
HAA instead of a HAV sequence (NH2-GTLHAASQVQ-amide; hu
SOD10), an alanine was replaced by a valine (NH2 GTLHAVSQVQ-
amide; hu SOD10mut). All 10-mer peptides (Innogenetics, Zwijnaarde,
Belgium and Ansynth Service, Roosendaal, The Netherlands) were
separated by HPLC to at least 95% purity. All 10-mer and 20-mer
peptides were used at a concentration of 200 m g/ml. In our previous
experiments (Willems et al., 1995), decapeptides exhibited a maximal
effect at this concentration.
MB2 is a mouse monoclonal antibody raised against MCF-7/AZ
cells, recognizing E-cadherin and with neutralizing effects (Bracke
et al., 1993). DECMA-1 is a rat monoclonal antibody raised against
the murine embryonal cell line PCC7 Aza RI and recognizing
murine and canine E-cadherin (Sigma). Rabbit IgG recognizing
chicken E-cadherin was kindly provided by R. M. Mège (Mège et
al., 1988).
Conditioned medium of the MDCKts.srcCl2 cells was obtained
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Table 1. Sequences of cadherin-derived or homologous peptides
Type Species Sequence Acronym
E-cadherin Human LFS HAV SSNG hu E-CAD10
Murine LYS HAV SSNG
Chicken LLS HAV SASG
Canine CAKYILYS HAV SSNGNAVED c E-CAD20
QLAKYILYS HA c E-CAD11flHAV
V SSNGNAVED c E-CADHAVfl10
LHSNSVGFSA hu E-CAD10scr
N-cadherin Human LRA HAV DING hu N-CAD10
Human CARFHLRA HAV DINGNQVENG hu N-CAD20
P-cadherin Human LFG HAV SENG hu P-CAD10
ECSODB Rat REM HAV SRQV Ra SOD10
ECSODC Rat mutated REM HAA SRQV Ra SOD10mut
Human GTL HAA SQVQ hu SOD10
Human mutated GTL HAV SQVQ hu SOD10mut
FGFR1 Human KKL HAV PAAK FGFR110
Hemagglutinin Influenza virus strain A LGH HAV SNGT HA(HMIVF)10
EC SOD, extracellular superoxide dismutase; FGFR, fibroblast growth factor receptor; HA(HMIVF), haemagglutinin of influenza virus A strain; flHAV, amino
acids flanking the HAV sequence at the left; HAVfl, amino acids flanking the HAV sequence at the right; scr, scrambled.as follows. Cells were grown to confluence in 75 cm2 tissue culture
plastic vessels (Becton Dickinson, Franklin Lakes, NJ). The cells
were washed 3 times with serum-free DMEM (Life Technologies)
and incubated at 40°C with serum-free DMEM. After 48 hours of
culture, the medium was harvested, centrifuged at 2,000 g for 30
minutes and filtered through a 0.22 m m filter to eliminate possible
cell particles. To remove E-cadherin fragments from the
conditioned medium, immunoprecipitations with DECMA-1 were
performed. The conditioned medium was incubated for 3 hours with
DECMA-1 at 4°C, followed by incubation with Protein G-
Sepharose 4 fast flow beads (Pharmacia, Uppsala, Sweden) for 1
hour. The supernatant was incubated for a second time for 3 hours
with DECMA-1 and 1 hour with Protein G-Sepharose 4 fast flow
beads. The medium was recuperated and filtered through a 0.22 m m
filter. The effect of conditioned medium containing E-cadherin
fragments or not was tested in the collagen invasion assay at a
dilution of 1:2.
To test the presence of E-cadherin fragments in the conditioned
medium, precipitated proteins were dissolved in sample buffer
(Laemmli, 1970), boiled in the presence of 5% (v/v) 2-
mercaptoethanol and separated by 7.5% SDS-PAGE. Proteins were
transferred onto Immobilon-P membrane (Millipore Corp., Bedford,
MA). After quenching with 5% (w/v) non-fat dry milk in PBS
containing 0.5% Tween-20, the membranes were incubated with
DECMA-1 as primary antibody, followed by 3 · 5 minutes washes and
incubation with alkaline phosphatase-conjugated secondary antibody.
Proteins were stained using nitro blue tetrazolium and 5-bromo-4-
chloro-3-indolyl phosphate (NBT/BCIP) as substrate.
Fast aggregation assay
Cell-cell adhesion was numerically evaluated in an aggregation assay
as described earlier (Bracke et al., 1993). Briefly, cells were detached
by collagenase A treatment (Boehringer Mannheim) followed by
trypsin, both in the presence of 0.04 mM Ca 2+. This procedure was
proven by flow cytometry to conserve E-cadherin expression on the
cell surface. The cells were allowed to aggregate on a Gyrotory shaker
(New Brunswick Scientific, New Brunswick, NJ) at 80 rounds per
minute for 30 minutes in an aggregation buffer containing 1.25 mM
Ca2+, 0.1 mg DNase/ml, 10 mM Hepes (4-(2-hydroxyethyl)piperazine
ethane-sulfonic acid) and 0.1% (w/v) bovine serum albumine (BSA)
and equilibrated at physiological pH and osmolarity. The aggregation
index was expressed as 1-N30/N0, where N0 indicates the initial
number of particles and N30 the number of particles after 30 minutes
of aggregation. The number of particles was measured by a Coultercounter ZM (Coulter Electronics, Luton, England). Cell aggregation
was also measured with an LS particle size analyser (LS 200, Coulter
Electronics). Here, relative volume in function of the particle size was
used as an index of aggregation (Vermeulen et al., 1995).
Slow aggregation assay
2· 104 cells in 200 m l medium with or without peptide or antibody
were seeded on top of 50 m l of a 0.66% (w/v) agar solution, that was
poured into a 96-well plate (Nunc, Roskilde, Denmark) at 50°C and
allowed to gel for 30 minutes at 4°C (Bracke et al., 1993).
MDCKts.srcCl2 cells were incubated for 2 hours at 37°C followed by
22 hours at 40°C. Aggregate formation was scored under an inverted
microscope with a · 10 objective (Leitz, Wetzlar, Germany) after 24
hours of incubation. Viability of the cells was checked by Trypan Blue
exclusion.
Collagen invasion assay
Collagen G (type I solution, Seromed, Biochrom KG, Berlin,
Germany) was dissolved at 0.22% (w/v) in bicarbonate buffer-
containing DMEM. 1.2 ml aliquots were poured into a 6-well plate
and incubated overnight at 37°C for gelation. Cells were seeded on
top of the collagen gel with or without peptides or antibody. After 24
hours of incubation at temperatures of 35°C, 37°C or 40°C, depending
on the cell line, the number of cells that invaded the gel as well as the
depth of the invasive cells was monitored under a microscope with a
computer-controlled step motor (Vakaet et al., 1991). The invasion
index was calculated as the number of cells inside the gel over the
total number of cells. The morphotype of the cells on top of the gel
was examined after 9 days of further culture.
Chick heart invasion assay
Invasion into embryonic chick heart fragments was tested as
described earlier (Mareel et al., 1979). Briefly, monolayer fragments
of cultured cells were confronted with 9-day-old precultured
embryonic chick heart fragments on a semi-solid agar medium. The
confronting pairs were incubated for 24 hours and transferred into an
Erlenmeyer flask with 1.5 ml of liquid culture medium. Peptide or
antibody, if present, was replaced by a fresh solution after 2 days.
Confronting pairs were fixed after 4 days, embedded in paraffin and
serially sectioned for staining with hematoxylin-eosin and
immunohistochemically with antisera either recognizing the chick
heart or the confronting cells. Invasion was scored on serial
histological sections as described earlier (Bracke et al., 1994).
Confronting cells possessing a functional E-cadherin/catenin
130 V. Noë and otherscomplex form an epithelioid layer around the heart tissue and do not
invade (Vleminckx et al., 1991).
Morphotype on solid substrate
For seeding on solid substrate, cells were detached with trypsin/EDTA
(Life Technologies) from a nearly confluent monolayer, suspended
and seeded at 1· 104 cells per ml in a 24-well plate. Cultures were
grown for about 3 days and when epithelioid islands were formed,
peptide or antibody was added. The cultures were scored for scattering
after 4 hours.
Statistics
All experiments were performed at least twice. Student’s t-test was
used for statistical analysis of the fast aggregation assay and of theTable 2. HAV-containing peptides or cadherin antibody in
expressing species-s
(E
am
MDCKts.srcCl2 MCF-7/AZ NM
(canine) (human) (mu
Treatment LYSHAVSSNG LFSHAVSSNG LYSHA
None 100±14 100±29 100
hu N-CAD10 99±6 84±5 84
hu N-CAD20 99±1
hu E-CAD10 31±4 47±2 15
c E-CAD20 18±3 47±1
hu P-CAD10 68±10 82
Ra SOD10 89±8 80
Ra SOD10mut 72±15
hu SOD10 78±2
FGFR110 58
Antibody 11±4 2±2 9
MDCKts.srcCl2 MDCK-ras-e c5
(canine) (canine)
LYSHAVSSNG LYSHAVSSNG
None 100±20 100±25
hu N-CAD10 81±27 80±39
hu N-CAD20 149±41
hu E-CAD10 350±57 688±117
hu E-CAD10scr 113±23
c E-CAD20 1089±155
c E-CAD11flHAV 68±5
c E-CADHAVfl10 86±14
hu P-CAD10 138±38
Ra SOD10
Ra SOD10mut
hu SOD10
hu SOD10mut
FGFR1 10
HA(HMIVF)10
Antibody 339±62 497±85
Numerical values indicate percentages of untreated ± s.d.; each experiment was
P<0.005 or *P<0.01 (Student’s t-test). hu E-CAD, human E-cadherin; c E-CAD, 
cadherin; Ra SOD, rat extracellular superoxide dismutase B; Ra SOD10mut, mutat
SOD10mut, mutated hu SOD; FGFR1, fibroblast growth factor receptor 1; HA(HM
the amino acids at the left of the HAV sequence; HAVfl, peptide containing the am
figures indicate number of amino acids; mut, mutated; antibody, MB2, a-ch E-cad
cells. Experiments with MDCKts.srcCl2 cells were done at 40°C. Activation of sr
321±55% of untreated cells at 40°C.collagen invasion assay. For all subjective observations (slow
aggregation, morphology and invasion into chick heart) 3 independent
observers scored coded samples.
RESULTS
Aggregation
E-cadherin dependent aggregation was examined in both a fast
(30 minutes) assay under Gyrotory shaking (Table 2 and Fig.
1) and a slow (24 to 48 hours) assay under static conditions
(Fig. 2). The Ca2+-dependent fast aggregation of all cells
expressing E-cadherin was inhibited by hu E-CAD10 peptide.hibit aggregation and stimulate collagen invasion of cells
pecific E-cadherins
Cell type
-cadherin species)
ino acid sequence
Fast aggregation
-e-ras NM-f-ras-TD-CAM5 2B2 VE-CHO Cl5a
rine) (murine) (chicken) (human)
VSSNG LYSHAVSSNG LLSHAVSASG LTAVIVDKQT
±14 100±11 100±17 100±9
±5 99±3 91±8 95±4
88±11
±2 45±2 82±8 91±7
86±10
±4 94±8 91±4
±2 101±3 94±4
81±6
84±6
±15 36±6
±8 8±9 5±1
Collagen Invasion
NM-e-ras NM-f-ras-TD-CAM5
(murine) (murine) NM-f-ras-TD1
LYSHAVSSNG LYSHAVSSNG (none)
100±15 100±10 100±13
94±22 57±15 92±21
247±21 257±27 126±11
143±17 110±19 121±17
85±21 87±15 84±9
127±31 127±23 96±12
169±41 107±16 102±11
256±37 169±14* 100±15
203±34* 104±11 110±19
199±24* 165±18* 110±11
505±38 254±25 98±20
 repeated at least twice; bold means significantly different from untreated with
canine E-cadherin; hu N-CAD, human N-cadherin; hu P-CAD, human P-
ed Ra SOD; hu SOD, human extracellular superoxide dismutase C; hu
IVF), hemagglutinin from influenza virus strain A; flHAV, peptide containing
ino acids at the right of the HAV sequence; scr, scrambled; the superscripts:
herin and DECMA-1, respectively, for human, chicken and canine or murine
c at 35°C reduced fast aggregation to 16±10% and increased invasion to
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Fig. 1. Inhibition at 40°C of fast aggregation of MDCKts.srcCl2 cells
by peptides hu E-CAD10 and hu N-CAD10 (A) and of MCF-7AZ
cells by hu E-CAD10 and hu P-CAD10 (B). Cells were detached
under E-cadherin-saving conditions, suspended in aggregation buffer
and allowed to aggregate for 30 minutes. Cell aggregation was
measured by particle size counting either after 0 minutes (peak
positions are indicated with an arrow) or 30 minutes of aggregation
(__). Aggregation of MDCKts.srcCl2 cells at 40°C (A) was inhibited
by hu E-CAD10 (d) and DECMA-1 (--). Treatment with hu N-
CAD10 (h) yields a biphasic curve, indicating inhibition of
aggregation of a subset of MDCKts.srcCl2 cells. Aggregation of
MCF7/AZ cells (B) was inhibited by hu E-CAD10 (d) and hu P-
CAD10 (s) peptides. Combination of both peptides (n) showed
additive inhibitory effects on MCF-7/AZ cell aggregation.
Fig. 2. Inhibition of aggregation of MDCKts.srcCl2 cells by
antibody DECMA-1 and peptide hu E-CAD10 but not by hu N-
CAD10. Cells were seeded on a gelified agar medium and incubated
at 37°C for 2 hours followed by incubation at 40°C for 22 hours
without added reagents (A), treated with hu N-CAD10 peptide
(B), hu E-CAD10 peptide (C) or treated with DECMA-1 antibody
(D). Aggregate formation was scored after 24 hours of incubation.
Addition of Trypan Blue at the end of the assay showed no dead
cells. Bar, 100 m m.Only the aggregation of 2B2 cells, expressing chicken E-
cadherin with a larger difference in the HAV-flanking amino
acids and aggregation of VE-CHO Cl5a, expressing VE-
cadherin not having an HAV sequence, could not be inhibited
by hu E-CAD10. HAV decapeptides with other flanking
sequences, e.g. hu N-CAD10 or hu P-CAD10, did not
significantly alter the aggregation index of cells expressing E-
cadherin (Table 2). The FGFR110 peptide (see Table 1) stands
as an exception since it also inhibited aggregation of NMuMG
cells expressing either the endogenous or an exogenous murine
E-cadherin (Table 2) as well as ARM cells expressing chicken
N-cadherin (data not shown). Also the 20-mer peptide c E-
CAD20 inhibited aggregation of MDCKts.srcCl2 cells at 40°C.Fast aggregation of MDCKts.srcCl2 cells was measured also
with an LS particle size analyzer. We found inhibition of
aggregation by 10-mer as well as 20-mer E-cadherin HAV
peptides and by the DECMA-1 antibody (Fig. 1A). Treatment
with N-cadherin peptide produced a biphasic curve, indicating
inhibition of aggregation in a subset of MDCKts.srcCl2 cells,
weakly expressing N-cadherin (data not shown). The minor
effects of other cadherin peptides was also investigated in
MCF-7/AZ cells. We also detected by western blotting, next to
E-cadherin, expression of P-cadherin but not of N-cadherin
(data not shown). By particle size counting, we found an
inhibition of aggregation by hu P-CAD10 that was additive to
hu E-CAD10 (Fig. 1B), while hu N-CAD10 had no significant
effect (data not shown).
Inhibition by hu E-CAD10 peptide of E-cadherin-specific
aggregate formation by MDCKts.srcCl2 cells at 40°C was also
shown in the slow aggregation assay (Fig. 2).
Invasion into collagen type I
Induction of invasion by peptides and antibodies into collagen
type I is shown in Table 2. At 40°C, invasion was induced in
MDCKts.srcCl2, up to the level of invasion at 35°C, by the
antibody DECMA-1, by hu E-CAD10 or c E-CAD20 but not by
hu N-CAD10 or hu N-CAD20, hu E-CAD10scr, c E-CAD11flHAV
or c E-CADHAVfl10, peptides containing the HAV-flanking
sequences of canine E-cadherin. A similar pattern of induction
of invasion was obtained at 37°C with MDCK-ras-e c5 and
with NMuMG derivatives expressing E-cadherin. In the latter
tests, hu N-CAD10 and hu P-CAD10 did not significantly alter
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- 80kDa
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Fig. 3. Induction of
invasion of
MDCKts.srcCl2 cells
into collagen type I by
conditioned medium
containing E-cadherin
fragments (A). The cells
were seeded on top of a
collagen I gel and
incubated at 40°C for 24
hours either untreated or in the presence of conditioned medium (CM), conditioned medium from which E-cadherin fragments were removed
by immunoprecipition with DECMA-1 (CM*), unconditioned medium (UCM) or unconditioned medium on which a sham
immunoprecipitation with DECMA-1 was performed (UCM*). The invasion index was calculated as the number of cells inside the gel over the
total number of cells. Bars are the means as percentages of untreated cells; flags are standard deviations, and shaded bars indicate significant
difference from untreated (P<0.005). Proteins immunoprecipitated by DECMA-1 from the conditioned medium (CM) or the unconditoned
medium (UCM) were separated by SDS-PAGE, blotted and immunostained with DECMA-1 followed by goat anti-rat alkaline phosphatase
conjugated antibody (lane 2 and 3) or with secondary antibody only (lane1) (B).invasion. The non-cadherin HAV-containing decapeptides hu
SOD10mut and HA(HMIVF)10 were, like hu E-CAD10, able to
induce invasion in the E-cadherin-positive NMuMG
derivatives. None of the decapeptides enhanced invasion of the
constitutively invasive E-cadherin-negative NM-f-ras-TD1
cells (data not shown).Fig. 4. Induction of invasion of
MDCKts.srcCl2 at 40°C in chick heart
fragments by hu E-CAD10 peptide.
MDCKts.srcCl2 cells were confronted with
9-day-old precultured embryonic chick heart
fragments on a semi-solid agar medium and
after 24 hours transferred into a liquid
medium and further cultured for 4 days.
Confronting pairs were then fixed, embedded
in paraffin and serially sectioned. Consecutive
sections of confrontation cultures of
MDCKts.srcCl2 cells, either untreated (A to
C) or treated with hu E-CAD10 (D to F) were
stained with hematoxyline-eosine (A and D),
antiserum against chick heart (B and E) or
with antiserum against MDCK cells (C and
F). Arrows in D to F mark invasive MDCK
cells. Bar, 50 m m.Also conditioned medium of MDCKts.srcCl2 cells,
containing the 80 kDa fragment of E-cadherin, induced
invasion of MDCKts.srcCl2 at 40°C. When cadherin fragments
were removed by immunoprecipitation with DECMA-1, the
conditioned medium did loose its ability to induce collagen
type I invasion (Fig. 3).
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Fig. 5. Peptide c E-CAD20 disturbs the epithelioid morphotype of
MDCKts.srcCl2 at 40°C on top of collagen I. MDCKts.srcCl2 cells
were detached with trypsin/EDTA, seeded on top of a collagen I gel
and incubated at 40°C. Photographs show non invading cells in focus
on top of the gel after 9 days of culture either untreated (A) or treated
with hu N-CAD20 (B) or c E-CAD20 peptide (C). Bar, 100 m m.
Fig. 6. Peptide hu E-CAD10 disturbs the epithelioid morphotype on
tissue culture plastic substratum. MDCK-ras-e c5 were detached
with trypsin/EDTA and seeded in a 24-well plate. When epithelioid
islands were formed, the cells were either left untreated (A) or
treated with hu E-CAD10 (B), DECMA-1 (C). Photographs were
taken 4 hours later. Bar, 50 m m.
A
B
C
A
B
CInvasion into chick heart
Three types of cells were tested also in the chick heart invasion
assay. MDCKts.srcCl2 cells formed an epithelioid cell layer
around the heart tissue after 4 days of confrontation at 40°C;
invasion was not observed (Fig. 4A,B,C). Confrontation
treatments with hu E-CAD10 (Fig. 4D,E,F) or with the
DECMA-1 antibody (data not shown) perturbed the epithelioid
organisation, and some MDCKts.srcCl2 cells were now found
inside the heart tissue. Hu E-CAD10 did neither induce invasion
nor interfere with the epithelioid organisation of NM-e-ras
cells surrounding the precultured heart fragment. With NM-f-
ras-TD-CAM5, not showing this epithelioid organisation
despite their expression of exogenous murine E-cadherin, no
induction of invasion by hu E-CAD10 or DECMA-1 was
observed (data not shown).
Morphotype on solid substrata
The function of the E-cadherin/catenin complex is also
reflected by the formation of epithelioid cell layers on solid
substrata. Indeed, MDCKts.srcCl2 cells at 40°C formed large
epithelioid colonies on top of collagen I (Fig. 5). In the
presence of hu E-CAD10, c E-CAD20 or DECMA-1, but not of
hu N-CAD10 or hu N-CAD20, the aggregates were much
smaller and less compact.Treatment of MDCK-ras-e c5 (Fig. 6) and MDCKts.srcCl2
cells cultured on tissue culture plastic substrate at 40°C with
hu E-CAD10 or DECMA-1 did induce scattering.
DISCUSSION
HAV-containing peptides, with an amino acid sequence similar
to the HAV-containing region of the first extracellular domain
of cadherins, were shown to inhibit cadherin-dependent
cellular functions. Using different cell lines, all expressing E-
cadherin, and several assays we were able to demonstrate
reproducible inhibition by HAV peptides homologous to E-
cadherin. Our assays include morphotype on solid substrate, on
collagen type I or in confronting organ culture with embryonic
chick heart, the fast and slow aggregation as well as invasion
into collagen type I or into precultured chick heart fragments.
All these phenotypes were shown to be E-cadherin-dependent
through inhibition with antibodies against E-cadherin.
The cadherin HAV peptides acted in a type- and species-
specific manner (Tables 1 and 2). Peptides homologous to E-
cadherin, but not peptides homologous to P- or N-cadherin,
were able to block cadherin-related functions in cells
expressing E-cadherin. The smaller degree of inhibition by hu
134 V. Noë and othersP-CAD10 of the fast aggregation of MCF-7/AZ cells could be
explained by the co-expression of P-cadherin on the surface of
these cells. Similarly, the weak expression of N-cadherin on
MDCKts.srcCl2 cells might explain the biphasic curve
obtained by particle size counting after incubation of these
cells with hu N-CAD10. Species-specificity is further
illustrated by the lack of inhibition by hu E-CAD10 of cadherin-
related functions in cells expressing chicken E-cadherin. Both
cadherin type-specific, and species-restricted activities suggest
that homology in the HAV-flanking amino acids determines
specificity. Limited differences in flanking amino acids
between E-cadherin of different species, e.g. human versus
murine or canine, do not interfere with the matching between
the peptide and the cadherin expressed on the test cells.
We demonstrated an important role for the HAV sequence
in the inhibition of E-cadherin functions, since peptides
containing the HAV flanking amino acids but not the full HAV
sequence and a scrambled peptide (see Table 1) were not
active. Some HAV-containing peptides homologous to
sequences of non-cadherin proteins showed E-cadherin
inhibitory activity in the aggregation and collagen type I
invasion assay despite large differences in HAV flanking
sequences as compared to the cadherins expressed by the test
cells. Such non-cadherin peptides did, however, underline also
the role of the HAV sequence since HAA congeners were not
active. Furthermore, they might reveal interactions between
cadherins and other molecules expressed at the cell surface.
Such interactions have been demonstrated already between N-
cadherin and FGFR1 and FGFR2 (Williams et al., 1994).
Another candidate for interactions with N-cadherin is
ECSODB, since the ECSODB peptide inhibited N-cadherin-
specific aggregation (Willems et al., 1995). These observations
and our present experiments with the peptide homologous to
the hemagglutinin of influenza virus (Stuart, 1994), suggest
that other non-cadherin HAV-containing peptides and proteins
might interfere with E-cadherin functions in an indirect way.
Quantitative and qualitative differences between the effects
of HAV peptides and antibody against cadherin are obvious in
our experiments. Depending upon the type of assay, the
inhibition of E-cadherin dependent activities by DECMA-1
was stronger than by hu E-CAD10. Elongation of the peptides
made them more potent inhibitors.
Our experiments with conditioned medium clearly show that
not only synthetic E-cadherin peptides but also E-cadherin
fragments, released in the medium, can induce invasion,
provided that their concentration is relatively high. Cadherin
proteins or peptides might be released to reach such a high
concentration in the tumor microenvironment, e.g. by secretion
or by proteolytic cleavage from the extracellular part of
cadherin. Moreover, mutations resulting in a premature stop
codon, as described in lobular breast carcinomas, may encode
secretory forms of E-cadherin (Berx et al., 1996). Enhanced
proteolysis has also been associated with invasion in
experimental and in clinical cancer (Chambers and Matrisian,
1997). Proteases degrade not only the peritumoral matrix but
may also cleave cell surface molecules. Such cleaved off
peptides may compete with the native molecule for ligand
binding as described for FGFR1 (Levi et al., 1996). Candidate
E-cadherin degrading proteases are u-PA and MMP9. u-PA is
upregulated in human breast cancer cells in culture after
incubation with the E-cadherin antibody DECMA-1 (Frixenand Nagamine, 1993). MMP 9 is activated during invasion of
the cytotrophoblast into the uterine wall and the activation is
concomitant with an increased turn-over of E-cadherin, release
of its 80 kDa fragments and replacement of E-cadherin by VE-
cadherin (Zhou et al., 1997). The elevated levels of cadherin
fragments in the urine and the plasma of cancer patients are
compatible with an increased turn-over of the transmembrane
E-cadherin protein (Katayama et al., 1994; Banks et al., 1995;
Griffiths et al., 1996).
In conclusion, our experiments show that E-cadherin/catenin
functions can be inhibited by homologous HAV-containing
peptides and E-cadherin fragments. These or similar E-
cadherin fragments may be released in an autocrine manner
and in this way contribute to the maintenance of the invasive
phenotype.
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